Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis：A Multicenter Randomized Controlled Clinical Trial

NCT04349683 is registered in ClinicalTrials.gov with Jemincare as lead sponsor.

NCT NCT04349683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04349683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis：A Multicenter Randomized Controlled Clinical Trial
Lead sponsor
Jemincare
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2020
Completion date
October 30, 2021
Enrollment
332 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 3b, chronic kidney disease stage4, glomerulonephritis